Medicare Enrolled
Dr. Amr Al-Hariri, M.D.
Internal Medicine · Templeton, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Al-Hariri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Al-Hariri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Al-Hariri
Dr. Amr Al-Hariri is an internal medicine specialist in Templeton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Al-Hariri performed 1,158 Medicare services across 1,022 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Hariri received a total of $13,993 from 73 pharmaceutical and/or device companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Hariri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 27% volume in CA
$13,993 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,158
Medicare services
Top 27% in CA for internal medicine
1,022
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| New patient office visit, complex (60-74 min) | 151 | $178 | $450 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
107 | $143 | $350 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
83 | $27 | $75 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
82 | $38 | $400 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
71 | $68 | $400 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
68 | $32 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
68 | $99 | $154 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
59 | $315 | $650 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
47 | $99 | $400 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
46 | $31 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $76 | $150 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
37 | $96 | $185 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
37 | $118 | $190 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
37 | $10 | $35 |
| Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | 37 | $102 | $195 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
37 | $75 | $160 |
| VEMP testing of lower inner ear nerve branch A diagnostic test that evaluates the function of the lower branch of the inner ear nerve. The procedure includes interpretation of the results and a written report. |
33 | $69 | $147 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
32 | $35 | $80 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
31 | $88 | $200 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
23 | $253 | $850 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
18 | $219 | $700 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
12 | $188 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,993
Total received (2018-2024)
Avg $1,999/year across 7 years
Top 8% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
678
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,720 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$273 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,906
2023
$2,351
2022
$2,256
2021
$1,354
2020
$1,180
2019
$2,221
2018
$1,726
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$684
Novartis Pharmaceuticals Corporation
$269
Amneal Pharmaceuticals LLC
$227
TG Therapeutics, Inc.
$225
Alexion Pharmaceuticals, Inc.
$156
Eisai Inc.
$121
PFIZER INC.
$113
Neurocrine Biosciences, Inc.
$110
Biogen, Inc.
$110
Teva Pharmaceuticals USA, Inc.
$106
MDD US Operations, LLC
$102
Lilly USA, LLC
$93
UCB, Inc.
$82
Celgene Corporation
$68
SK Life Science, Inc.
$64
CSL Behring
$52
ACADIA Pharmaceuticals Inc
$51
Kyowa Kirin, Inc.
$36
ARGENX US, INC.
$34
Lundbeck LLC
$29
Alnylam Pharmaceuticals Inc.
$27
Grifols USA, LLC
$24
LivaNova USA, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$23
NEUROPACE, INC.
$23
SCILEX PHARMACEUTICALS INC.
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Octapharma USA, Inc.
$14
Top 3 companies account for 40.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,451
ABBVIE INC.
$1,135
AbbVie Inc.
$940
Biogen, Inc.
$786
Supernus Pharmaceuticals, Inc.
$786
EMD Serono, Inc.
$767
Alexion Pharmaceuticals, Inc.
$654
Teva Pharmaceuticals USA, Inc.
$550
SK Life Science, Inc.
$487
Amneal Pharmaceuticals LLC
$457
Neurocrine Biosciences, Inc.
$440
UCB, Inc.
$345
Lilly USA, LLC
$343
Sunovion Pharmaceuticals Inc.
$307
CSL Behring
$292
PFIZER INC.
$274
Amgen Inc.
$269
MDD US Operations, LLC
$259
ACADIA Pharmaceuticals Inc
$242
TG Therapeutics, Inc.
$225
Eisai Inc.
$192
ARGENX US, INC.
$188
Lundbeck LLC
$170
Grifols USA, LLC
$165
Acorda Therapeutics, Inc
$145
Avanir Pharmaceuticals, Inc.
$145
Celgene Corporation
$139
W. L. Gore & Associates, Inc.
$132
GENZYME CORPORATION
$129
Genentech USA, Inc.
$99
EISAI INC.
$90
Impax Laboratories, Inc.
$88
Janssen Pharmaceuticals, Inc
$67
TG THERAPEUTICS, INC.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$64
Kyowa Kirin, Inc.
$56
Greenwich Biosciences, Inc.
$54
Biohaven Pharmaceuticals, Inc.
$54
Mallinckrodt Hospital Products Inc.
$51
GE HEALTHCARE
$50
Catalyst Pharmaceuticals, Inc.
$47
Upsher-Smith Laboratories LLC
$45
IMPEL PHARMACEUTICALS INC.
$44
Banner Life Sciences, LLC
$44
Ipsen Biopharmaceuticals, Inc
$42
Allergan, Inc.
$38
LivaNova USA, Inc.
$36
MITSUBISHI TANABE PHARMA AMERICA, INC.
$33
JAZZ PHARMACEUTICALS INC.
$33
Bayer HealthCare Pharmaceuticals Inc.
$29
Mallinckrodt Enterprises LLC
$28
Alnylam Pharmaceuticals Inc.
$27
Adamas Pharmaceuticals, Inc.
$27
GE HealthCare
$26
Allergan Inc.
$24
NEUROPACE, INC.
$23
E.R. Squibb & Sons, L.L.C.
$22
SCILEX PHARMACEUTICALS INC.
$21
BANNER LIFE SCIENCES, LLC
$21
Biohaven Pharmaceutical Holding Company Ltd.
$20
AQUESTIVE THERAPEUTICS, INC.
$19
ASSERTIO THERAPEUTICS, Inc.
$18
AbbVie, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$17
Akcea Therapeutics, Inc.
$17
Mylan Pharmaceuticals Inc.
$17
Jazz Pharmaceuticals Inc.
$17
Vertical Pharmaceuticals, LLC
$17
Merck Sharp & Dohme Corporation
$16
ASSERTIO THERAPEUTICS, INC.
$15
Octapharma USA, Inc.
$14
Merck Sharp & Dohme LLC
$13
Boston Scientific Corporation
$12
Top 3 companies account for 25.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AVONEX · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BRIUMVI · Betaseron · Briviact · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · CREXONT · Cambia · DIVIGEL · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RNS Neurostimulator Kit · RYTARY · Rebif · SOLIRIS · SPRAVATO · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UNITHROID · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XYREM · XYWAV · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
87
Per 100K population
30.9
County median income
$93,398
Nearest hospital
ADVENTIST HEALTH TWIN CITIES
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Al-Hariri is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Hariri experienced with new patient office visit, complex (60-74 min)?
Based on Medicare claims data, Dr. Al-Hariri performed 151 new patient office visit, complex (60-74 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Al-Hariri receive payments from pharmaceutical companies?
Yes. Dr. Al-Hariri received a total of $13,993 from 73 companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Al-Hariri's costs compare to other internal medicine physicians in Templeton?
Dr. Al-Hariri's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Al-Hariri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Templeton
Browse internal medicine physicians in Templeton ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology